Zdrowie i gospodarka · 14/02/2020

FDA Extends Comment Period for Draft Guidance on Combination Products

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on bridging for drug-device and biologic-device combination products, following requests from interested persons for an additional time frame to submit comments.